Connor, Clark & Lunn Investment Management (CC&L)’s Avanos Medical AVNS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-45,668
| Closed | -$1.1M | – | 1410 |
|
|
2024
Q3 | $1.1M | Buy |
45,668
+16,929
| +59% | +$407K | 0.01% | 856 |
|
|
2024
Q2 | $572K | Buy |
28,739
+8,210
| +40% | +$164K | ﹤0.01% | 1020 |
|
|
2024
Q1 | $409K | Sell |
20,529
-1,440
| -7% | -$28.7K | ﹤0.01% | 1183 |
|
|
2023
Q4 | $493K | Buy |
21,969
+1,247
| +6% | +$28K | ﹤0.01% | 1049 |
|
|
2023
Q3 | $419K | Buy |
20,722
+504
| +2% | +$10.2K | ﹤0.01% | 1062 |
|
|
2023
Q2 | $517K | Buy |
+20,218
| New | +$517K | ﹤0.01% | 976 |
|
|
2022
Q2 | – | Sell |
-9,373
| Closed | -$314K | – | 1036 |
|
|
2022
Q1 | $314K | Buy |
+9,373
| New | +$314K | ﹤0.01% | 864 |
|
|
2019
Q2 | – | Sell |
-5,400
| Closed | -$230K | – | 981 |
|
|
2019
Q1 | $230K | Buy |
+5,400
| New | +$230K | ﹤0.01% | 803 |
|
|
2018
Q1 | – | Sell |
-37,617
| Closed | -$1.74M | – | 715 |
|
|
2017
Q4 | $1.74M | Sell |
37,617
-52,126
| -58% | -$2.41M | 0.01% | 438 |
|
|
2017
Q3 | $4.04M | Sell |
89,743
-72,675
| -45% | -$3.27M | 0.02% | 326 |
|
|
2017
Q2 | $6.38M | Buy |
162,418
+25,725
| +19% | +$1.01M | 0.04% | 241 |
|
|
2017
Q1 | $5.21M | Sell |
136,693
-900
| -0.7% | -$34.3K | 0.03% | 245 |
|
|
2016
Q4 | $5.09M | Buy |
137,593
+20,500
| +18% | +$758K | 0.03% | 249 |
|
|
2016
Q3 | $4.06M | Buy |
117,093
+20,300
| +21% | +$704K | 0.03% | 271 |
|
|
2016
Q2 | $3.15M | Buy |
96,793
+18,700
| +24% | +$608K | 0.02% | 297 |
|
|
2016
Q1 | $2.24M | Buy |
78,093
+37,125
| +91% | +$1.07M | 0.02% | 321 |
|
|
2015
Q4 | $1.37M | Buy |
+40,968
| New | +$1.37M | 0.01% | 396 |
|